Loading...
Would the Recommended Dose Have Been Different Using Novel Dose-Finding Designs? Comparing Dose-Finding Designs in Published Trials
Simulation studies have shown that novel designs such as the continual reassessment method and the Bayesian optimal interval (BOIN) design outperform the 3 + 3 design by recommending the maximum tolerated dose (MTD) more often, using less patients, and allotting more patients to the MTD. However, it...
Na minha lista:
| Udgivet i: | JCO Precis Oncol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer Health
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8232832/ https://ncbi.nlm.nih.gov/pubmed/34250415 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.21.00136 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|